Adell Harriman & Carpenter’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.94M Buy
22,575
+567
+3% +$202K 0.48% 46
2025
Q4
$7.2M Buy
22,008
+1,609
+8% +$510K 0.43% 44
2025
Q3
$5.76M Buy
20,399
+1,018
+5% +$295K 0.35% 57
2025
Q2
$5.41M Buy
19,381
+203
+1% +$57.5K 0.36% 55
2025
Q1
$5.98M Buy
19,178
+2,890
+18% +$853K 0.45% 53
2024
Q4
$4.25M Sell
16,288
-412
-2% -$122K 0.3% 65
2024
Q3
$5.38M Sell
16,700
-545
-3% -$178K 0.39% 62
2024
Q2
$5.39M Sell
17,245
-205
-1% -$60.2K 0.42% 59
2024
Q1
$4.96M Buy
17,450
+187
+1% +$54.7K 0.41% 59
2023
Q4
$4.97M Buy
17,263
+170
+1% +$46.3K 0.46% 57
2023
Q3
$4.59M Buy
17,093
+655
+4% +$163K 0.48% 58
2023
Q2
$3.7M Sell
16,438
-935
-5% -$217K 0.38% 67
2023
Q1
$4.2M Sell
17,373
-1,022
-6% -$251K 0.45% 63
2022
Q4
$4.83M Sell
18,395
-1,108
-6% -$297K 0.56% 59
2022
Q3
$4.4M Sell
19,503
-550
-3% -$133K 0.54% 58
2022
Q2
$4.88M Sell
20,053
-409
-2% -$100K 0.6% 55
2022
Q1
$4.95M Sell
20,462
-1,445
-7% -$332K 0.48% 64
2021
Q4
$4.93M Sell
21,907
-2,768
-11% -$584K 0.46% 60
2021
Q3
$5.25M Sell
24,675
-3,320
-12% -$764K 0.55% 58
2021
Q2
$6.82M Sell
27,995
-609
-2% -$150K 0.72% 47
2021
Q1
$7.12M Sell
28,604
-399
-1% -$95.2K 0.86% 41
2020
Q4
$6.67M Sell
29,003
-135
-0.5% -$31.1K 0.88% 40
2020
Q3
$7.41M Buy
29,138
+1,214
+4% +$301K 1.11% 30
2020
Q2
$6.59M Buy
27,924
+155
+0.6% +$35.4K 1.13% 31
2020
Q1
$5.63M Sell
27,769
-1,275
-4% -$278K 1.19% 29
2019
Q4
$7M Sell
29,044
-3,341
-10% -$736K 1.15% 32
2019
Q3
$6.27M Buy
32,385
+1,140
+4% +$219K 1.14% 33
2019
Q2
$5.76M Sell
31,245
-351
-1% -$62.8K 1.08% 35
2019
Q1
$6M Sell
31,596
-824
-3% -$157K 1.17% 31
2018
Q4
$6.31M Buy
32,420
+2,878
+10% +$561K 1.39% 27
2018
Q3
$6.12M Buy
29,542
+77
+0.3% +$15.2K 1.15% 31
2018
Q2
$5.44M Buy
29,465
+1,231
+4% +$218K 1.08% 35
2018
Q1
$4.81M Sell
28,234
-31
-0.1% -$5.69K 1% 38
2017
Q4
$4.92M Buy
28,265
+51
+0.2% +$9.03K 1.04% 34
2017
Q3
$5.26M Buy
28,214
+932
+3% +$165K 1.15% 31
2017
Q2
$4.7M Sell
27,282
-1,079
-4% -$175K 1.06% 36
2017
Q1
$4.65M Buy
28,361
+984
+4% +$164K 1.07% 39
2016
Q4
$4M Sell
27,377
-4,654
-15% -$700K 1% 42
2016
Q3
$5.34M Buy
32,031
+444
+1% +$75.1K 1.35% 29
2016
Q2
$4.81M Sell
31,587
-950
-3% -$148K 1.26% 34
2016
Q1
$4.88M Sell
32,537
-2,575
-7% -$383K 1.31% 34
2015
Q4
$5.7M Buy
35,112
+5,475
+18% +$861K 1.53% 21
2015
Q3
$4.1M Buy
29,637
+649
+2% +$102K 1.2% 35
2015
Q2
$4.45M Buy
28,988
+2,835
+11% +$454K 1.15% 29
2015
Q1
$4.18M Buy
26,153
+1,000
+4% +$157K 1.1% 31
2014
Q4
$4.01M Buy
25,153
+5,025
+25% +$783K 1.09% 34
2014
Q3
$2.38M Hold
20,128
0.66% 53
2014
Q2
$2.38M Buy
20,128
+70
+0.3% +$8.1K 0.66% 53
2014
Q1
$2.47M Buy
20,058
+1,165
+6% +$141K 0.73% 49
2013
Q4
$2.16M Buy
18,893
+115
+0.6% +$13.1K 0.67% 50
2013
Q3
$2.1M Sell
18,778
-200
-1% -$21.7K 0.59% 46
2013
Q2
$1.87M Buy
+18,978
New +$1.97M 0.67% 47

Other funds holding AMGN

Adell Harriman & Carpenter's AMGN Position: Q1 2026 in Review

Adell Harriman & Carpenter increased its Amgen (AMGN) stake by 2.6% in Q1 2026, buying an estimated $202K and bringing the position to 22,575 shares worth $7.94M. The position accounts for 0.48% of the portfolio, ranked #46.

Adell Harriman & Carpenter first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Adell Harriman & Carpenter held 22,575 shares of Amgen worth $7.94M as of Q1 2026.
  • Adell Harriman & Carpenter bought 567 Amgen shares in Q1 2026, an estimated $202K.
  • Amgen made up 0.48% of Adell Harriman & Carpenter's portfolio in Q1 2026, its #46 holding.
  • Adell Harriman & Carpenter first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Adell Harriman & Carpenter's 13F filing for Q1 2026, filed 4 May 2026.